- Home
- KNSL vs MEDP Comparison
KNSL vs MEDP Comparison
Compare KNSL & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSL
- MEDP
- Stock Information
- Founded
- KNSL 2009
- MEDP 1992
- Country
- KNSL United States
- MEDP United States
- Employees
- KNSL N/A
- MEDP N/A
- Industry
- KNSL Property-Casualty Insurers
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- Sector
- KNSL Finance
- MEDP Health Care
- Exchange
- KNSL Nasdaq
- MEDP Nasdaq
- Market Cap
- KNSL 10.9B
- MEDP 10.5B
- IPO Year
- KNSL 2016
- MEDP 2016
- Fundamental
- Price
- KNSL $428.53
- MEDP $340.22
- Analyst Decision
- KNSL Hold
- MEDP Buy
- Analyst Count
- KNSL 10
- MEDP 10
- Target Price
- KNSL $476.75
- MEDP $389.89
- AVG Volume (30 Days)
- KNSL 210.0K
- MEDP 310.8K
- Earning Date
- KNSL 02-13-2025
- MEDP 02-10-2025
- Dividend Yield
- KNSL 0.16%
- MEDP N/A
- EPS Growth
- KNSL 34.49
- MEDP 42.23
- EPS
- KNSL 17.78
- MEDP 12.63
- Revenue
- KNSL $1,587,525,000.00
- MEDP $2,109,054,000.00
- Revenue This Year
- KNSL N/A
- MEDP $7.54
- Revenue Next Year
- KNSL $14.98
- MEDP $11.55
- P/E Ratio
- KNSL $24.06
- MEDP $27.15
- Revenue Growth
- KNSL 29.65
- MEDP 11.84
- 52 Week Low
- KNSL $355.13
- MEDP $302.01
- 52 Week High
- KNSL $548.47
- MEDP $459.77
- Technical
- Relative Strength Index (RSI)
- KNSL 37.15
- MEDP 47.17
- Support Level
- KNSL $434.00
- MEDP $336.78
- Resistance Level
- KNSL $487.35
- MEDP $347.58
- Average True Range (ATR)
- KNSL 16.40
- MEDP 12.05
- MACD
- KNSL -4.35
- MEDP -0.79
- Stochastic Oscillator
- KNSL 5.45
- MEDP 34.48
About KNSL Kinsale Capital Group Inc.
Kinsale Capital Group Inc is an insurance holding company. The company is engaged in offering property, casualty, and specialty insurance products. It offers specialty insurance products for allied health, healthcare, life sciences, a professional, and a public entity. The company operates in only one reportable segment which is the Excess and Surplus Lines Insurance segment, which includes commercial excess and surplus lines liability and property insurance products through its underwriting divisions. The company generates revenues in the form of premiums and investment income.
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.